ETD system

Electronic theses and dissertations repository

 

Tesi etd-06092017-020610


Thesis type
Tesi di specializzazione (5 anni)
Author
CAVALIERE, ILENIA
URN
etd-06092017-020610
Title
Resezioni polmonari maggiori con tecnica robotica in pazienti affetti da NSCLC: risultati oncologici a lungo termine
Struttura
PATOLOGIA CHIRURGICA, MEDICA, MOLECOLARE E DELL'AREA CRITICA
Corso di studi
CHIRURGIA TORACICA
Commissione
relatore Prof. Mussi, Alfredo
relatore Prof.ssa Melfi, Franca
Parole chiave
  • NSCLC
  • chirurgia toracica
  • chirurgia robotica
Data inizio appello
05/07/2017;
Consultabilità
completa
Riassunto analitico
The aim of this study was to analyse the results of robotic lobectomy for lung cancer.<br>Clinical records of 212 patients who underwent robotic major surgery from January 2010 to December 2015 for NSCLC were retrospectively analyzed; 127 male and 85 female. Mean age was 66,3 months (range 30 – 82).<br>Surgical procedures consisted in 57 right upper lobectomy, 17 medium lobectomy, 74 right lower lobectomy, 34 left upper lobectomy, 29 left lower lobectomy and 1 superior bilobectomy.<br>Mean operative time was 215 minutes (range 65 – 460), mean chest drainage duration was 3,6 days (range 2 – 13) and mean postoperative stay was 6,6 days (range 4 – 29).<br>Mean disease free survival was 66,3 months (range 1 – 83). Disease free survival carcer-correlated was for adenocarcinoma 66,4 months (range 1 – 83), for squamous cell carcinoma 64,4 months (range 6 – 82) and for other histology was 47,6 months (range 6 – 58).<br>Disease free survival stage-correlated for stage I was 75,6 months (range ); for stage II was 42,3 months (range 1 – 67); for stage III 51,2 months (range 19 – 74) for stage IV 10,3 months (range 0 – 12). <br>Mean overall survival was 78,6 months (range 4 – 83). <br>Overall survival carcer-correlated was for adenocarcinoma 79,2 months (range 4 – 83), for squamous cell carcinoma 79 months (range 12 – 82) and for other histology was 48,8 months (range 17 – 58).<br>Overall survival stage-correlated for stage I was 82 months (range 9 – 83), for stage II was 73,5 months (range 10 – 82) for stage III was 61,4 months (range 22 – 68) and for stage IV 68 months.<br>Robotic lung surgery is one of the most innovative and increasingly widespread techniques, due to to high-definition 3D vision and great maneuverability permit to perform pulmonary resection. <br>The extended intuitive dexterity offered by the endo-wristed robotic instruments complemented by excellent magnified stereoscopic view, allows to perform a radical dissection, and the mini-invasive approach guarantees minimal injury to patients.<br>This study suggests a positive oncological outcomes for patients NSCLC affected who underwent robotic major surgery.<br>
File